United States · FDA National Drug Code directory
VOTRIENT
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-1077_026e2548-8de0-4776-9802-dd3fff2c2635
- Product NDC
- 0078-1077
- Form
- TABLET, FILM COATED
- Composition / generic term
- pazopanib hydrochloride
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20160712
- Source listing expiry
- 20261231
Source-listed ingredients
- PAZOPANIB HYDROCHLORIDE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET, FILM COATED in 1 BOTTLE (0078-1077-66) · 0078-1077-66
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →